New drug shows promise for rare muscle diseases
NCT ID NCT04033926
First seen Nov 19, 2025 · Last updated May 14, 2026 · Updated 22 times
Summary
This study tested an experimental drug called KZR-616 in 25 adults with active polymyositis or dermatomyositis, two rare diseases that cause muscle inflammation and weakness. Participants received weekly injections of the drug or a placebo for 16 weeks, then switched to the other option for another 16 weeks. The goal was to see if the drug improves muscle strength and function safely.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DERMATOMYOSITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
KZR Research Site
Beverly Hills, California, 90211, United States
-
KZR Research Site
Orange, California, 92868, United States
-
KZR Research Site
Miami, Florida, 33136, United States
-
KZR Research Site
Atlanta, Georgia, 30322, United States
-
KZR Research Site
Kansas City, Kansas, 66160, United States
-
KZR Research Site
Baltimore, Maryland, 21224, United States
-
KZR Research Site
Ann Arbor, Michigan, 48109, United States
-
KZR Research Site
Great Neck, New York, 11021, United States
-
KZR Research Site
Duncansville, Pennsylvania, 16635, United States
-
KZR Research Site
Pittsburgh, Pennsylvania, 15213, United States
-
KZR Research Site
Austin, Texas, 78756, United States
-
KZR Research Site
Henrico, Virginia, 23233, United States
-
KZR Research Site
Prague, Czechia
-
KZR Research Site
Göttingen, Germany
Conditions
Explore the condition pages connected to this study.